Delivery Order SPE2DB22D2006-SPE2DB25FV5WA

Award Date 10/24/24
Potential Completion Date 10/25/24
Potential Value $24K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $16,574.80, is for the delivery of PREVNAR 20 vaccine syringes. The contract has a firm fixed price pricing type and an ultimate completion date of November 14, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PREVNAR 20 vaccine syringes. The contract has a ceiling value of $5,204.83 and runs through March 17, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a major pharmaceutical distributor. The contract is for the supply of PREVNAR 20 syringes, a pneumococcal vaccine, valued at $14,671.30. The contract is a firm fixed-price, delivery order type, with an ultimate completion date of November 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
The U.S. Defense Logistics Agency (DLA) awarded a $9,574.62 Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PREVNAR 20 vaccine syringes. This award is not associated with a set-aside program. The contract has an ultimate completion date of July 22, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical for delivering a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,633.77 firm fixed-price contract is for the provision of PREVNAR 20 syringes (0.5ML) and has an ultimate completion date of January 30, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PREVNAR 20 vaccine syringes. The contract, which is not set aside, has a ceiling value of $7,978.80 and a final completion date of September 9, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PREVNAR 20 SYRINGE 0.5ML, a pneumococcal vaccine, and has a ceiling value of $34,229.28. The contract is a firm-fixed-price delivery order with a performance period ending on September 17, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,487.04, is for the delivery of Prevnar 20 Syringe 0.5mL, a vaccine product, with a completion date of November 5, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of PREVNAR 20 syringes, a pneumococcal conjugate vaccine, valued at $8,144.82. The contract has a firm fixed price and an ultimate completion date of November 25, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,218.38 firm fixed-price delivery order is for the supply of PREVNAR 20 syringes, a vaccine product. The contract has an ultimate completion date of January 24, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB25FV5WA
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Prevnar 20 syringes, a pneumococcal vaccine. It has a firm fixed-price, with a ceiling value of $24,192.74, and an ultimate completion date of October 25, 2024.

Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for federal beneficiaries.

Generated 1/23/25, 9:27 AM